Notice of Correction for RFA-MH-18-702 "Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33- Clinical Trial Required)"

Notice Number: NOT-MH-19-016

Key Dates
Release Date : February 04, 2019

Related Announcements
RFA-MH-18-702

Issued by
National Institute of Mental Health (NIMH)

Purpose

This Notice is to correct the key dates section for RFA-MH-18-702 "Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33- Clinical Trial Required)"

Currently reads:

Application Due Dates: February 14, 2018, June 15, 2018; October 15, 2018, February 15, 2019, June 15, 2019; October 15, 2019, February 14, 2020, June 15, 2020; October 15, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Scientific Merit Review:June 2018, October 2018, March 2019

Advisory Council Review:October 2018, January 2019, May 2019

Modified to Read

Scientific Merit Review:June 2018, October 2018, March 2019, June 2019, October 2019, March 2020, June 2020, October 2020, March 2021,

Advisory Council Review:October 2018, January 2019, May 2019,October 2019, January 2020, May 2020, October 2020, January 2021, May 2021

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

For Pediatric Studies

Margaret Grabb, Ph.D.
National Institute of Mental Health (NIMH)
Telephone: 301-443-3563
Email: mgrabb@mail.nih.gov

For Adult Studies

Mi Hillefors, M.D., Ph.D.
National Institute of Mental Health (NIMH)
Telephone: 301-443-2738
Email: mi.hillefors@nih.gov

For Geriatric Studies

Jovier Evans, Ph.D.
National Institute of Mental Health (NIMH)
Telephone: 301-443-6328
Email: jevans1@mail.nih.gov